BioRestorative Therapies Inc - Company Profile
Powered by 
All the sales intelligence you need on BioRestorative Therapies Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how BioRestorative Therapies Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with BioRestorative Therapies Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
BioRestorative Therapies Inc (BRT) is a developer of therapeutic products and medical therapies. Its therapies are designed to address unmet needs in patients suffering from highly prevalent conditions. The company's product candidates include BRTX 100, a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases. BRT leverages ThermoStem technology platform which develops brown fat stem cell-based therapy for the treatment of type 2 diabetes, obesity, and other metabolic disorders. Its BioCosmeceuticals leverages cutting-edge secretome technology for cosmetic and dermatological applications. BRT is headquartered in Melville, New York, the US.
Headquarters
United States of America
Address
Suite One, 40 Marcus Drive, Melville, New York, 11747
Website
www.biorestorative.com
Telephone
1 631 7608100
No of Employees
13
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
BRTX (NASD)
Revenue (2024)
$359,700
-10.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-58.6%
(2024 vs 2023)
Market Cap*
$5.3M
Net Profit Margin (2024)
XYZ
-76.8%
(2024 vs 2023)
* As of and is in US$
BioRestorative Therapies Inc premium industry data and analytics
Products and Services
| Products |
|---|
| BRTX- 100: Chronic Lumbar Disc Diseases |
| Platform: |
| ThermoStem Technology Platform |
Competitor Comparison
| Key Parameters | BioRestorative Therapies Inc | Nature's Sunshine Products Inc | Lisata Therapeutics Inc | Palisade Bio Inc | Stemline Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Melville | Lehi | Basking Ridge | Danver | New York City |
| State/Province | New York | Utah | New Jersey | California | New York |
| No. of Employees | 13 | 806 | 21 | 14 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lance Alstodt | Chief Executive Officer; Chairman; President | Executive Board | 2020 | 54 |
| Francisco Silva | Vice President - Research and Development; Director; Secretary | Executive Board | 2020 | 50 |
| Robert E. Kristal | Chief Financial Officer | Senior Management | 2021 | 58 |
| Zachary Smith | Vice President - Biocosmeceuticals Division | Senior Management | 2026 | - |
| Nickolay Kukekov, Ph.D. | Director | Non Executive Board | 2021 | 51 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer